Midostaurin
Showing 51 - 58 of 58
Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapse Trial in
Unknown status
- Acute Lymphoblastic Leukemia Recurrent
- +4 more
- INA03 administration
-
Marseille, Bouches-du Rhône, France
- +1 more
Feb 4, 2020
Acute Myeloid Leukemia, MDS Trial in Los Angeles, Boston, New York (Itraconazole, PKC412)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Los Angeles, California
- +3 more
Aug 7, 2017
Acute Myeloid Lukemia Trial in France (Ponatinib and Cytarabine)
Active, not recruiting
- Acute Myeloid Lukemia
- Ponatinib and Cytarabine
-
Aix-en-Provence, France
- +36 more
Aug 6, 2020
Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following, Myelodysplastic Syndrome Trial in Columbus
Completed
- Acute Myeloid Leukemia
- +10 more
- midostaurin
- +4 more
-
Columbus, OhioThe Ohio State University Medical Center
Jul 4, 2016
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (midostaurin)
Terminated
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- midostaurin
-
Seattle, Washington
- +7 more
Nov 18, 2015
Indolent Systemic Mastocytosis Trial in Groningen (Midostaurin,)
Unknown status
- Indolent Systemic Mastocytosis
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jan 15, 2015
Leukemia, Myeloid, Acute Trial in St. Louis (Granulocyte colony-stimulating factor (G-CSF), Cladribine, Cytarabine)
Completed
- Leukemia, Myeloid, Acute
- Granulocyte colony-stimulating factor (G-CSF)
- +4 more
-
St. Louis, MissouriWashington University School of Medicine
Jul 22, 2013
Acute Myeloid Leukemia Trial in Kansas City (combination therapy using decitabine and midostaurin)
Completed
- Acute Myeloid Leukemia
- combination therapy using decitabine and midostaurin
-
Kansas City, KansasUniversity of Kansas Medical Center, Westwood Campus
Mar 25, 2013